Thus, these data suggest that ASC-derived IL-6 and HGF can reprogram CD44v6- progenitors into CD44v6 + cells, which can increase their metastatic potential by secreting NGF and recruiting ASCs within tumor mass. The gene discussed is HGF; the disease is neoplasm.